Crossmark

Co-designing primary and secondary outcome measures for an international phase 3 trial of surgical de-escalation in vulvar cancer through a consumer workshop

Crossref DOI link: https://doi.org/10.1186/s40900-026-00902-8

Published Online: 2026-06-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Angel, Lauren

Janda, Monika

Martin, Andrew

Armstrong, Brianna

Williams, Merran

Thaler, Nicola Du

Wild, Emma

Li, Mary

Obermair, Andreas
Funding

Funding for this research was provided by:

National Health and Medical Research Council (2035386)

Cherish Women’s Cancer Foundation
License Information

Text and Data Mining valid from 2026-06-15

Version of Record valid from 2026-06-15
More Information

Article History

Received: 17 December 2025

Accepted: 30 April 2026

First Online: 15 June 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below